Patents by Inventor Frank H. Gawin

Frank H. Gawin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aversive treatment of stimulant abuse
    Patent number: 6281213
    Abstract: Psychomotor stimulant addiction in humans is treated by administering to a human patient before or during a hypodopaminergic “crash” following the psychomotor stimulant induced hyperdopaminergic high or within a period of 3 hours to 21 days prior thereto, a dosage of a pharmaceutically active neuroleptic compound effective to produce aversion to any psychomotor stimulant taken within this period.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: August 28, 2001
    Inventors: Frank H. Gawin, Elena Khalsa-Dennison
  • Method for treatment of substance addiction
    Patent number: 5468749
    Abstract: Certain azapirone compounds and their pharmaceutically acceptable salts are useful in the treatment of substance addiction.
    Type: Grant
    Filed: June 16, 1989
    Date of Patent: November 21, 1995
    Inventors: Frank H. Gawin, Robert Byck, Marc Alderdice, Jeffrey Schwimmer
  • Treating habit disorders
    Patent number: 5223497
    Abstract: A method for treating habit disorders in a human patient comprising administering to the patient an anti-habitual amount of a pharmaceutically active compound, which results in activation of a brain reward system, e.g., flupenthixol, or esters thereof or pharmaceutically acceptable salts thereof, either alone or in admixture with a physiologically acceptable diluent.
    Type: Grant
    Filed: March 4, 1992
    Date of Patent: June 29, 1993
    Assignee: Yale University
    Inventors: Frank H. Gawin, Brian G. Humblestone, David F. Allen
  • Method for treatment of substance addiction
    Patent number: 5185329
    Abstract: Certain azapirone compounds and their pharmaceutically acceptable salts are useful in the treatment of substance addiction.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: February 9, 1993
    Assignee: Bristol-Myers Squibb Company
    Inventors: Frank H. Gawin, Robert Byck, Marc Alderdice, Jeffrey Schwimmer
  • Treating habit disorders
    Patent number: 5114942
    Abstract: A method for treating habit disorders in a human patient comprising administering to the patient an antihabitual amount of a pharmaceutically active compound, which results in activation of a brain reward system, e.g., flupenthixol, or esters thereof or pharmaceutically acceptable salts thereof, either alone or in admixture with a physiologically acceptable diluent.
    Type: Grant
    Filed: January 15, 1991
    Date of Patent: May 19, 1992
    Assignee: Yale University
    Inventors: Frank H. Gawin, Brian G. Humblestone, David F. Allen
  • Treating habit disorders
    Patent number: 5059600
    Abstract: A method for teating habit disorders in a human patient comprising administering to the patient an anti-habitual amount of a pharmaceutically active compound, which results in activation of a brain reward system, e.g., flupenthixol, or esters thereof or pharmaceutically acceptable salts thereof, either alone or in admixture with a physiologically acceptable diluent.
    Type: Grant
    Filed: March 31, 1989
    Date of Patent: October 22, 1991
    Assignee: Yale University
    Inventors: Frank H. Gawin, Brian G. Humblestone, David F. Allen